参考文献/References:
[1] HE M,HUANG W,ZHENG Y,HUANG L,ELLWEI L B.Refractive error and visual impairment in school children in rural southern China[J].Ophthalmology,2007,114(2):374-382.
[2] WU X X,MENG X S,LI H P,CHEN Y Y.Changes of eye movementers after appropriate treatment for 7-12year old school-age myopic children[J].Int Eye Sci,2015,15(10):1833-1836.
吴西西,孟宪实,黎海平,陈摇珏.7~12岁近视学龄儿童合理矫治后对调节眼动参数的影响[J].国际眼科杂志,2015,15(10):1833-1836.
[3] LIN L,MAN F T,HU N B,LIU H X,JIA G Z,WANG P Y.Study on risk factors of myopia in adolescents[J].Chin J Child Health Care,2013,21(2):206-209.
林林,满丰韬,胡乃宝,刘海霞,贾改珍,王萍玉.青少年近视的危险因素研究[J].中国儿童保健杂志,2013,21(2):206-209.
[4] WU Y,DING L L,YANG L P,CAO X.Appliccation of compound tropicamide and atropine in mydriatic refractometry for ametropia chilerens[J].Pract Phar Clin Remed,2014,17(9):1203-1205.
吴艳,丁莉莉,杨丽萍,曹茜.复方托吡卡胺和硫酸阿托品在儿童散瞳验光中的效果评价[J].实用药物与临床,2014,17(9):1203-1205.
[5] HUANG W R.Comparative study of mydrin-P and atropine ointment in children’s amblyopia[J].J Med Forum,2011,32(6):142-143.
黄蔚茹.美多丽与阿托品眼膏在儿童弱视验光作用的比较探讨[J].医药论坛杂志,2011,32(6):142-143.
[6] LIU C P.Clinical evaluation of tropicamide eye drops in preventing and treating juvenile pseudmyopia[J].J Med Theory Pract,2015,28(20):2799-2800.
柳翠萍.托吡卡胺滴眼液防治青少年假性近视临床效果初评[J].医学理论与实践,2015,28(20):2799-2800.
[7] DONG L Y,KANG X L,WANG Y F.Comparison of effects of cyclopentolate hydrochloride,compound tropicamide and artopine on ciliary paralysis[J].J Shanghai Jiao Tong Univ(Medical Edition),2011,31(10):1432-1435.
董凌燕,亢晓丽,王亚夫.盐酸环喷托酯 、复方托吡卡胺与阿托品睫状肌麻痹作用的比较[J].上海交通大学学报(医学版),2011,31(10):1432-1435.
[8] FISCHER A J,MIETHKE P,MORGAN I G,STELL W K.Cholinergic amacrine cells are not required for the progression and atropine-mediated suppression of form-deprivation myopia[J].Brain Res,1998,794(1):48-60.
[9] CHIA A,CHUA W H,CHEUNG Y B,WONG W L,LINGHAM A,FONG A,et al.Atropine for the treatment of childhood myopia:safety and efficacy of 0.5%,0.1%,and 0.01% doses(Atropine for the Treatment of Myopia 2)[J].Ophthalmology,2012,119(2):347-354.
[10] ZHENG Z G,LIU B,FANG Y,HUA X L,LIAO H F.Clinical observation of mydriasis combined with progressive change tablets in the treatment of juvenile myopia[J].Zhejiang Med J,2013,35(1):35-37.
郑志刚,刘博,方燕,华雪莲,廖慧芳.散瞳联合灰变渐进片治疗青少年近视的临床观察[J].浙江医学,2013,35(1):35-37.
[11] LIANG D L,YU X B,YU J W,XIONG Z,GU R S.A comparative study of different concentrations of atropine eye gel for retarding the development of myopia in children [J].Chin J Strab Pediatr Ophthalmol,2013,21(2):20-22.
梁斗立,于雪冰,俞佳伟,熊壮,顾若姝.不同浓度阿托品眼用凝胶间断使用延缓儿童近视发展的对比研究[J].中国斜视与小儿眼科杂志,2013,21(2):20-22.
[12] ZHONG R Y,YU L,GUAN G H.Clinical observation of comprehensive therapy for treatment of myopia in teenagers and children[J].J Guangzhou Univ Tradit Chin Med,2015,32(6):1004-1007.
钟瑞英,于蓝,关国华.综合疗法预防少年儿童近视的临床研究[J].广州中医药大学学报杂志,2015,32(6):1004-1007.
[13] REN Q J,YUE H,WANG P,LIU R J,LV P.Effects of concentration atropine and orthokeratology on myopia prevention and control[J].Int Eye Sci,2017,17 (4):794-796.
任秋锦,岳辉,王平,刘仁建,吕鹏.低浓度阿托品与角膜塑形镜控制近视疗效对比[J].国际眼科杂志,2017,17 (4):794-796.
[14] LI P.Atropine eye gel application in delaying the development of children’s myopia[J].Chin J Strab Pediatr Ophthalmol,2015,23(3):42-44.
李鹏.阿托品眼用凝胶在儿童延缓近视中的应用[J].中国斜视与小儿眼科杂志,2015,23(3):42-44.
[15] ZHOU L,SHEN J.The long-term effects of different administration of 1% atropine on the myopia progression in adolescents with low myopia[J].Ophthalmology,2014,23(2):111-114.
周磊,沈降.1%阿托品不同用药方式对控制青少年低度近视进展的远期效果[J].眼科,2014,23(2):111-114.
[16] WU H,YIN Y X,ZHAO C N.The applicatio effect of compound tropicamide in mydriatic optometry of children myopia [J].Med Innov Chin,2015,14(28):56-59.
吴红,殷育茜,赵春宁.复方托吡卡胺滴眼液在近视儿童散瞳验光中的应用效果[J].中国医学创新,2015,14(28):56-59.
[17] FENG L H.Observation on the effect of compound tropicamide eye drops in mydriasis optometry in myopic children[J].Modern Diag Treat,2017,28(3):456-457.
冯丽华.复方托吡卡胺滴眼液在近视儿童散瞳验光中的应用效果观察[J].现代诊断与治疗,2017,28(3):456-457.
相似文献/References:
[1]计垣.近视的分子遗传学研究进展[J].眼科新进展,2012,32(6):000.
[2]张卫霞 曾照年 唐秀侠 孙宏霞 李洪润.Zywave波前像差仪在近视屈光不正测量中的应用[J].眼科新进展,2012,32(7):000.
[3]闵红波 刘小红 花雷 韩文龙 储明慧 邵娟英.近视对OCT测量视网膜神经纤维层厚度的影响[J].眼科新进展,2012,32(12):000.
[4]刘太祥 李海祥 石容 王铮.ORK程序中两种切削模式治疗近视术后角膜像差变化及对视觉功能的影响[J].眼科新进展,2013,33(1):000.
[5]陈月芹 黄振平 薛春燕 葛轶睿.有晶状体眼虹膜固定型人工晶状体植入术后房角宽度的改变[J].眼科新进展,2013,33(6):000.
[6]王凌飞 杨瑞波 赵少贞.CACHET有晶状体眼人工晶状体植入术后视觉质量的临床评价[J].眼科新进展,2013,33(6):000.
[7]胡裕坤 李文静 高晓唯 董晶 郭云林.飞秒激光微小切口角膜基质透镜切除术治疗近视对角膜波前像差的影响[J].眼科新进展,2013,33(7):000.
[8]许瑶 曾骏文.近视眼药物治疗研究进展[J].眼科新进展,2013,33(7):000.
[9]汤勇 刘才远.LASIK、Epi-LASIK、SBK、Fem-LASIK及SMILE术中角膜切削误差的对比研究[J].眼科新进展,2013,33(9):000.
[10]吴玉伟 李筱荣 张琰 赵雅丽 王晓燕.无酒精LASEK治疗近视和近视散光的临床疗效[J].眼科新进展,2013,33(9):000.
[11]李静一,刘群,李长安,等.户外活动和0.1 g·L阿托品对学龄期儿童控制近视发展的疗效对比[J].眼科新进展,2019,39(2):158.[doi:10.13389/j.cnki.rao.2019.0036]
LI Jing-Yi,LIU Qun,LI Chang-An,et al.Comparison of outdoor activities and 0.1 g·L atropine in preventing myopia progression in children[J].Recent Advances in Ophthalmology,2019,39(7):158.[doi:10.13389/j.cnki.rao.2019.0036]
[12]刘媛媛,冯雪亮,张馨心.0.1 g·L阿托品不同给药频次对青少年屈光不正患者屈光度及调节功能的影响[J].眼科新进展,2023,43(3):212.[doi:10.13389/j.cnki.rao.2023.0043]
LIU Yuanyuan,FENG Xueliang,ZHANG Xinxin.Effects of different administration frequencies of 0.1 g·L atropine on the diopter and accommodation function of adolescents with refraction error[J].Recent Advances in Ophthalmology,2023,43(7):212.[doi:10.13389/j.cnki.rao.2023.0043]
[13]申笛,周堃,孙西宇,等.角膜塑形镜联合0.1 g·L阿托品延缓儿童近视进展分析[J].眼科新进展,2023,43(11):882.[doi:10.13389/j.cnki.rao.2023.0177]
SHEN Di,ZHOU Kun,SUN Xiyu,et al.Efficacy of orthokeratology combined with 0.1 g·L atropine in slowing the progression of myopia in children[J].Recent Advances in Ophthalmology,2023,43(7):882.[doi:10.13389/j.cnki.rao.2023.0177]